High Point Advisor Group LLC Teva Pharmaceutical Industries LTD Transaction History

High Point Advisor Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $74,213 - $104,582	-10,056 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $84,269 - $102,370	10,056 New	10,056 $98,000
Q3 2019 Nov 12, 2019	SELL	$6.16 - $9.6 $76,112 - $118,617	-12,356 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$8.12 - $15.72 $4,579 - $8,866	-564 Reduced 4.37%	12,356 $95,000
Q1 2019 May 08, 2019	BUY	$15.58 - $20.01 $16,125 - $20,710	1,035 Added 8.71%	12,920 $188,000
Q4 2018 Feb 20, 2019	BUY	$14.59 - $23.84 $16,822 - $27,487	1,153 Added 10.74%	11,885 $214,000
Q3 2018 Oct 24, 2018	BUY	$21.06 - $25.65 $226,015 - $275,275	10,732 New	10,732 $228,000

604

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.